ClinicalTrials.gov

History of Changes for Study: NCT04296643
Medical Masks vs N95 Respirators for COVID-19
Latest version (submitted January 11, 2023) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 March 3, 2020 None (earliest Version on record)
2 November 16, 2020 Recruitment Status, Study Status, Contacts/Locations and Oversight
3 February 9, 2021 Sponsor/Collaborators and Study Status
4 December 21, 2022 Recruitment Status, Study Status, Study Design, Contacts/Locations, Outcome Measures, Study Description and Eligibility
5 January 11, 2023 Study Status and Contacts/Locations
Comparison Format:

Scroll up to access the controls

Changes (Merged) for Study: NCT04296643
November 16, 2020 (v2) -- February 9, 2021 (v3)

Changes in: Study Status and Sponsor/Collaborators

Open or close this module Study Identification
Unique Protocol ID: 20006014
Brief Title: Medical Masks vs N95 Respirators for COVID-19
Official Title: Medical Masks Versus N95 Respirators to Prevent 2019 Novel Coronavirus Disease (COVID-19) in Healthcare Workers: A Randomized Trial
Secondary IDs:
Open or close this module Study Status
Record Verification: March 2020
Overall Status: Recruiting
Study Start: April 1, 2020
Primary Completion: February 1, 2021 [Anticipated]
Study Completion: April 1, 2021 [Anticipated]
First Submitted: March 3, 2020
First Submitted that
Met QC Criteria:
March 3, 2020
First Posted: March 5, 2020 [Actual]
Last Update Submitted that
Met QC Criteria:
November 16, 2020 February 9, 2021
Last Update Posted: November 18, 2020 [Actual] February 12, 2021 [Actual]
Open or close this module Sponsor/Collaborators
Sponsor: McMaster University
Responsible Party: Sponsor
Collaborators: Vancouver Coastal Health
University of Alberta
Dalhousie University
Open or close this module Oversight
U.S. FDA-regulated Drug: No
U.S. FDA-regulated Device: No
Data Monitoring: Yes
Open or close this module Study Description
Brief Summary: A randomized controlled trial in which nurses will be randomized to either medical masks or N95 respirators when providing care to patients with COVID-19.
Detailed Description: A randomized controlled trial in which nurses will be randomized to either medical masks or N95 respirators when providing medical care to patients with COVID-19. This Canadian multi-centre randomized controlled trial will assess whether medical masks are non-inferior to N95 respirators when nurses provide care involving non-aerosol generating procedures. Nurses will be randomized to either use of a medical mask or to a fit-tested N95 respirator when providing care for patients with febrile respiratory illness. The primary outcome is laboratory confirmed COVID-19 among nurse participants.
Open or close this module Conditions
Conditions: Coronavirus
N95
Medical Mask
Keywords:
Open or close this module Study Design
Study Type: Interventional
Primary Purpose: Prevention
Study Phase: Not Applicable
Interventional Study Model: Parallel Assignment
Number of Arms: 2
Masking: Single (Outcomes Assessor)
Allocation: Randomized
Enrollment: 576 [Anticipated]
Open or close this module Arms and Interventions
Arms Assigned Interventions
Experimental: Medical Mask
Medical Mask worn when providing care to patient with febrile respiratory illness
Device: Medical Mask
Medical Mask (known also as Surgical Mask)
Active Comparator: N95 respirator
N95 respirator worn when providing care to patient with febrile respiratory illness
Device: N95 respirator
N95 respirator
Open or close this module Outcome Measures
Primary Outcome Measures:
1. RT-PCR confirmed COVID-19 infection
[ Time Frame: 6 months ]

Number of participants with RT-PCR confirmed COVID-19 infection
Secondary Outcome Measures:
1. Acute respiratory illness
[ Time Frame: 6 months ]

Number of participants with acute respiratory illness
2. Absenteeism
[ Time Frame: 6 months ]

Number of participants with absenteeism
3. Lower respiratory infection
[ Time Frame: 6 months ]

Number of participants with lower respiratory infection
4. Pneumonia
[ Time Frame: 6 months ]

Number of participants with pneumonia
5. ICU admission
[ Time Frame: 6 months ]

Number of participants with ICU admission
6. Mechanical ventilation
[ Time Frame: 6 months ]

Number of participants needing mechanical ventilation
7. Death
[ Time Frame: 6 months ]

Number of participants that died
Open or close this module Eligibility
Minimum Age: 18 Years
Maximum Age:
Sex: All
Gender Based:
Accepts Healthy Volunteers: No
Criteria:

Inclusion Criteria:

  • Nurses who work > 37 hours per week in medical, emergency, pediatric units

Exclusion Criteria:

  • Nurses with one or more comorbidities
  • Nurses who cannot pass an N95 respirator fit-test
Open or close this module Contacts/Locations
Central Contact Person: Mark Loeb, MD
Telephone: 9053340010
Email: loebm@mcmaster.ca
Study Officials: Mark B Loeb
Principal Investigator
McMaster University
Locations: Canada, Alberta
Foothills Medical Centre
[Recruiting]
Calgary, Alberta, Canada, T2N 1N4
Contact:Contact: John Conly, MD
Contact:Principal Investigator: John Conly, MD
University of Alberta Hospital
[Recruiting]
Edmonton, Alberta, Canada
Contact:Contact: Stephanie Smith, MD
Contact:Principal Investigator: Stephanie Smith, MD
Canada, Ontario
Brantford General Hospital
[Recruiting]
Brantford, Ontario, Canada
Contact:Contact: Verne Glavin, MD
Contact:Principal Investigator: Verne Glavin, MD
Hamilton Health Sciences
[Recruiting]
Hamilton, Ontario, Canada
Contact:Contact: Dominik Mertz, MD
Contact:Principal Investigator: Dominik Mertz, MD
St. Joseph's Healthcare
[Recruiting]
Hamilton, Ontario, Canada
Contact:Contact: Zain Chagla, MD
Contact:Principal Investigator: Zain Chagla, MD
Ottawa Hospital
[Recruiting]
Ottawa, Ontario, Canada, K1H 8L6
Contact:Contact: Lana Castellucci, MD
Contact:Principal Investigator: Lana Castellucci, MD
Hopital Montfort
[Recruiting]
Ottawa, Ontario, Canada, K1K 0T2
Contact:Contact: Sarah Mansour, MD
Contact:Principal Investigator: Sarah Mansour, MD
Niagara Health Services
[Recruiting]
St. Catherines, Ontario, Canada
Contact:Contact: Karim Ali, MD
Contact:Principal Investigator: Karim Ali, MD
St. Joe's Unity Health
[Recruiting]
Toronto, Ontario, Canada
Contact:Contact: Mark Downing, MD
Contact:Principal Investigator: Mark Downing, MD
St. Mike's Unity Health
[Recruiting]
Toronto, Ontario, Canada
Contact:Contact: Matthew Muller, MD
Contact:Principal Investigator: Matthew Muller, MD
Canada, Quebec
Montreal University Health Centre
[Recruiting]
Montréal, Quebec, Canada
Contact:Contact: Charles Frenette, MD
Contact:Principal Investigator: Charles Frenette, MD
The Jewish General Hospital
[Recruiting]
Montréal, Quebec, Canada
Contact:Contact: Leighanne Parkes, MD
Contact:Principal Investigator: Leighanne O Parkes, MD
Israel
Golden Care LTCF
[Recruiting]
Tzrifin, Israel
Contact:Contact: Ilan Youngster, MD
Contact:Principal Investigator: Ilan Youngster, MD
Open or close this module IPDSharing
Plan to Share IPD:
Open or close this module References
Links:
Available IPD/Information:

Scroll up to access the controls Scroll to the Study top

U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services